Retour aux projets

17451.1 PFLS-LS

17451.1 PFLS-LS

Résumé

Discovery and Development of Novel Drug Candidates for the Treatment of Diabetes

Textes supplémentaires

Abstract

G-protein coupled receptors (GPCR) are the target of close to half of marketed drugs. Growing|awareness that a single GPCR can govern multiple response pathways has opened the door|for the next generation of GPCR therapeutics that act as differentiated drugs. We combine cell signaling excellence and industrial drug development experience to build an innovative GPCR platform to radically refine molecule development for key pharmaceutical targets, and apply the|platform to discover first-in-class small molecule therapeutics for Diabetes.

Participants

Daniel Fitzgerald

Wirtschaftspartner

df@geneva-biotech.com

GBiotech Sarl (DBA Geneva Biotech) Daniel Fitzgerald Avenue de la Roseraie 64 1205 Genève GE CH

Pierre Maechler

Kontaktperson

Pierre.Maechler@unige.ch

Université de Genève Pierre Maechler Rue du Général Dufour 24 1211 Genève GE CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2015-05-31
Date de fin
2018-11-30
Coûts totaux approuvés
CHF 477780.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%